摘要
目的:探讨断藤益母汤(DTYMT)对破骨细胞活性及Wnt信号通路的影响。方法:通过诱导RAW264. 7巨噬细胞建立体外破骨细胞培养体系;设空白组、模型组、断藤益母汤400、600、800、1000μg/m L浓度组、甲氨蝶呤2μg/m L组,然后通过CCK-8法检测细胞生存率,蛋白免疫印迹法检测Wnt信号通路关键蛋白表达。结果:TRAP染色试验显示,与模型组相比,DTYMT 800、1000μg/m L浓度组融合细胞数目显著减少,具有统计学意义(P 〈0. 01)。CCK-8结果显示,与模型组比较,DTYMD 600、800、1000μg/m L浓度组和甲氨蝶呤2μg/m L组生存率明显下降(P 〈0. 05,P 〈0. 01)。免疫蛋白印迹结果显示,与模型组相比,DTYMT 800、1000μg/m L、甲氨蝶呤2μg/m L组中Wnt3a、β-catenin蛋白表达量显著上升(P 〈0. 05,P 〈0. 01),DKK1蛋白表达水平显著下降(P 〈0. 05,P 〈0. 01)。结论:断藤益母汤可能是通过影响Wnt信号通路,即上调Wnt3a、β-catenin蛋白表达、下调DDK1蛋白表达以及抑制破骨细胞的分化和增殖而起到减缓RA的骨破坏作用。
Objective: To investigate the effect of DTYMT on Wnt signaling pathway and MMP-9 in osteoclasts.Methods: In vitro osteoclast culture system was established by inducing RAW264. 7 macrophages. Blank group,model group,methotrexate group of 2 μg/m L and DTYMD groups of 400,600,800,1000 μg/m L were set up. Cell viability was then measured by CCK-8 and the expression of key protein in Wnt signaling pathway was detected by Western blotting. Results:The TRAP staining showed that the number of fusion cells was reduced in the DTYMT 800 μg/m L and 1000μg/m L concentrations compared to the model group(P〈0. 01). CCK-8 results showed that DTYMD 600,800,1000μg/m L concentration groups and methotrexate 2 μg/m L group significantly reduced OC survival rate compared with model group( P〈0. 05,P〈0. 01). The expressions of Wnt3 a and β-catenin protein in DTYMT 800,1000 μg/m L and methotrexate 2 μg/m L groups were significantly increased compared with that of the model group( P〈0. 05,P〈0. 01),and the expression of DKK1 protein was significantly decreased( P 〈0. 05,P〈0. 01). Conclusion: DTYMT may play a role in mitigating the bone destruction of RA by affecting Wnt signaling pathway,that is up-regulation of Wnt3 a,β-catenin protein expressions,down-regulation of DDK1 protein expression and inhibition of osteoclast differentiation and proliferation.
作者
蔡叙东
林昌松
潘东梅
李楠
姜玉宝
丘文宇
郭添枫
CAI Xudong;LIN Changsong;PAN Dongmei;LI Nan;JIANG Yubao;QIU Wenyu;GUO Tianfeng(Guangzhou University of Chinese Medicine,Guangzhou 510405,Guangdong,China;The First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510405,Guangdong,China)
出处
《中华中医药学刊》
CAS
北大核心
2018年第10期2332-2335,I0006,共5页
Chinese Archives of Traditional Chinese Medicine
基金
国家自然科学基金项目(81774262,81573930)
广东省自然科学基金项目(2014A030313403,2017A030311009)